Low Neutralizing Antibody Titers against the Mu Variant of SARS-CoV-2 in 31 BNT162b2 Vaccinated Individuals in Colombia

Global surveillance programs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are showing the emergence of variants with mutations in the spike protein. Genomic and laboratory surveillance are important to determine if these variants may be more infectious or less susceptible to anti...

Descripción completa

Detalles Bibliográficos
Autores principales: Álvarez-Díaz, Diego A., Muñoz, Ana Luisa, Tavera-Rodríguez, Pilar, Herrera-Sepúlveda, María T., Ruiz-Moreno, Hector Alejandro, Laiton-Donato, Katherine, Franco-Muñoz, Carlos, Pelaez-Carvajal, Dioselina, Cuellar, Diego, Muñoz-Suarez, Alejandra M., Galindo, Marisol, Arias-Ramírez, Edgar J., Mercado-Reyes, Marcela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876570/
https://www.ncbi.nlm.nih.gov/pubmed/35214639
http://dx.doi.org/10.3390/vaccines10020180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876570/
https://www.ncbi.nlm.nih.gov/pubmed/35214639
http://dx.doi.org/10.3390/vaccines10020180

Ejemplares similares